Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
The NYPH-Weill Cornell Medical Center Gastrointestinal Oncology Registry
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 14, 2020
The LUCINDA Trial
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 16, 2020
Indications for Use of CD34 Selection Column (CliniMACS-Miltenyi Biotec)
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 12, 2020
A Multi-center Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adults Patients with Hematologic Malignancies and Other Indications
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 12, 2020
Protocol for A Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 12, 2020
National Marrow Donor Program (NMDP) and Center for International Blood and Marrow Transplant Research (CIBMTR) – Research Database for Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 12, 2020
Advancing Liver Therapeutic Approaches (ALTA). The ALTA Consortium Study Group for the Management of Portal Hypertension – A 5-year Longitudinal Observation Study of Patients with Cirrhosis Undergoing TIPS Placement
Study Status:
Open to Enrollment
Primary Investigator:
Date: September 10, 2020
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
Study Status:
Open to Enrollment
Primary Investigator:
Date: September 15, 2020
Phase I/II Dose-Escalation Study of Fractionated and Multiple Dose 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date: October 8, 2020
Single-Arm Phase II Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 13, 2021